ARTICLE | Clinical News
EC approves Pfizer's Trumenba
August 4, 2017 4:46 PM UTC
In May, the European Commission approved Trumenba meningococcal group B vaccine (recombinant LP2086, PF-5212366) from Pfizer Inc. (NYSE:PFE) to prevent invasive meningococcal disease caused by Neisse...
BCIQ Company Profiles